Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.

Pileggi GS, Da Mota LMH, Kakehasi AM, De Souza AW, Rocha A, de Melo AKG, da Fonte CAM, Bortoletto C, Brenol CV, Marques CDL, Zaltman C, Borba EF, Reis ER, Freire EAM, Klumb EM, Christopoulos GB, Laurindo IMM, Ballalai I, Da Costa IP, Michelin L, de Azevêdo Valadares LD, Chebli LA, Lacerda M, Toscano MAF, Yazbek MA, De Abreu Vieira RMR, Magalhães R, Kfouri R, Richtmann R, Merenlender SDCS, Valim V, De Assis MR, Kowalski SC, Trevisani VFM.

Adv Rheumatol. 2019 Apr 29;59(1):17. doi: 10.1186/s42358-019-0056-x.

PMID:
31036077
2.

Arthritis and arthralgia as an adverse event following immunization: A systematic literature review.

Panozzo CA, Pourmalek F, Brauchli Pernus Y, Pileggi GS, Woerner A, Bonhoeffer J; Brighton Collaboration Aseptic Arthritis Working Group.

Vaccine. 2019 Jan 7;37(2):372-383. doi: 10.1016/j.vaccine.2018.06.067. Epub 2018 Nov 28.

PMID:
30502066
3.

Signs and symptoms of rheumatic diseases as first manifestation of pediatric cancer: diagnosis and prognosis implications.

Fonseca MB, Gomes FHR, Valera ET, Pileggi GS, Gonfiantini PB, Gonfiantini MB, Ferriani VPL, Carvalho LM.

Rev Bras Reumatol Engl Ed. 2017 Jul - Aug;57(4):330-337. doi: 10.1016/j.rbre.2017.01.007. Epub 2017 Feb 10. English, Portuguese.

4.

Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey.

Kahwage PP, Ferriani MP, Furtado JM, de Carvalho LM, Pileggi GS, Gomes FH, Terreri MT, Magalhães CS, Pereira RM, Sacchetti SB, Marini R, Bonfá E, Silva CA, Ferriani VP.

Clin Rheumatol. 2017 Mar;36(3):547-553. doi: 10.1007/s10067-016-3534-0. Epub 2017 Jan 9.

PMID:
28070763
5.

New strategy for testing efficacy of immunotherapeutic compounds for diabetes in vitro.

Pileggi GS, Clemencio AD, Malardo T, Antonini SR, Bonato VL, Rios WM, Silva CL.

BMC Biotechnol. 2016 May 10;16(1):40. doi: 10.1186/s12896-016-0270-0.

6.

Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.

Ferreira JC, Marques HH, Ferriani MP, Gormezano NW, Terreri MT, Pereira RM, Magalhães CS, Campos LM, Bugni V, Okuda EM, Marini R, Pileggi GS, Barbosa CM, Bonfá E, Silva CA.

Lupus. 2016 Jun;25(7):754-9. doi: 10.1177/0961203315627203. Epub 2016 Jan 27.

PMID:
26821966
7.

HIV/AIDS and rheumatoid arthritis.

Cunha BM, Mota LM, Pileggi GS, Safe IP, Lacerda MV.

Autoimmun Rev. 2015 May;14(5):396-400. doi: 10.1016/j.autrev.2015.01.001. Epub 2015 Jan 8. Review.

PMID:
25578483
8.

2012 Brazilian Society of Rheumatology Consensus on vaccination of patients with rheumatoid arthritis.

Brenol CV, da Mota LM, Cruz BA, Pileggi GS, Pereira IA, Rezende LS, Bertolo MB, Freitas MV, Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, Pinheiro Gda R; Brazilian Society of Rheumatology.

Rev Bras Reumatol. 2013 Feb;53(1):4-23. English, Portuguese.

9.

Vaccination for patients with rheumatoid arthritis: a pressing need.

Brenol CV, Pileggi GS.

Rev Bras Reumatol. 2013 Feb;53(1):1-3. English, Portuguese. No abstract available.

10.

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases.

Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi GS, Borte M, Wulffraat NM; EULAR.

Ann Rheum Dis. 2011 Oct;70(10):1704-12. doi: 10.1136/ard.2011.150193. Epub 2011 Aug 3.

PMID:
21813547
11.

Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids.

Pileggi GS, de Souza CB, Ferriani VP.

Arthritis Care Res (Hoboken). 2010 Jul;62(7):1034-9. doi: 10.1002/acr.20183.

Supplemental Content

Loading ...
Support Center